The general consensus is it would be a positive factor and one that would lead to share price appreciation as it would net ~60million as per where the company was prior to this update (would double check that). Right now it's being seen as a the low margin business, and really the gain from it's sell would be a positive from an institution perspective.
AVA chart, page-162
Featured News
Add AVA (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $39.16M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 13.0¢ | $260 | 2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99999 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 270841 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99999 | 0.130 |
4 | 46950 | 0.125 |
5 | 128291 | 0.120 |
2 | 243478 | 0.115 |
3 | 115454 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 270841 | 6 |
0.140 | 164132 | 5 |
0.145 | 61004 | 2 |
0.150 | 233943 | 5 |
0.155 | 235327 | 7 |
Last trade - 10.00am 15/11/2024 (20 minute delay) ? |
Featured News
AVA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
Previous Video
Next Video
SPONSORED BY The Market Online